Back to Insights
Military & Defense20 min read

Blast Exposure and Military TBI

The case for standardized biomarker screening in military neurotrauma — covering blast biology, deployment protocols, veteran claims, and population health.

Over 400,000 U.S. service members have been diagnosed with TBI since 2000, and that figure undercounts blast exposure that never reached formal diagnosis. The measurement gap is not theoretical — it has shaped careers, benefits decisions, and long-term health.

Blood-based biomarkers offer a path to standardized, mission-compatible screening that closes that gap.

01

The Measurement Gap

Blast injury rarely produces obvious imaging findings. A service member exposed to repeated low-level blasts during training or operations may have no documented “TBI event” in their record while accumulating measurable neurological change.

That gap matters operationally (fitness for duty) and administratively (disability claims) and clinically (long-term care).

02

Subclinical Blast Injury

Blast wave physics damage the brain through mechanisms distinct from impact concussion. Diffuse axonal injury, white matter changes, and inflammatory cascade can occur without loss of consciousness or visible symptoms.

Biomarkers can detect that subclinical damage, especially when measured against a pre-deployment baseline.

03

Pre- and Post-Deployment Screening

A baseline draw before deployment, paired with a return draw after, produces individualized exposure data. Changes from baseline are interpretable in a way population norms are not.

That same protocol applies to high-exposure training environments — breachers, gunners, EOD — where cumulative exposure is the operational reality.

04

Return-to-Duty Decisions

After a documented blast or impact event, biomarker results provide medical leadership with objective input on fitness for return. The decision remains clinical, but it is no longer made on symptom report alone.

That matters for the service member, the unit, and mission effectiveness.

05

Veteran Disability Claims

Veterans seeking service-connected disability for TBI face a familiar problem: years between exposure and claim, with imaging that often shows nothing. NfL, with its long half-life and trajectory utility, can document persistent axonal injury well after the inciting event.

Combined with service records and clinical history, biomarker evidence strengthens the evidentiary basis for claims.

06

Population-Level Policy

Standardized biomarker screening across a force produces population data — exposure prevalence, recovery profiles, long-term trajectory. That data informs operational policy, training design, and resource allocation.

The same approach scales to law enforcement and first responder populations with comparable exposure profiles.

Continue the Conversation